| Preface | 4 |
|---|
| Acknowledgements | 6 |
|---|
| Contributors | 9 |
|---|
| Contents | 7 |
|---|
| 1 The Beautiful Structures of BAFF, APRIL, and Their Receptors | 12 |
|---|
| 1.1 Introduction | 13 |
| 1.2 Multiple Forms of BAFF and APRIL | 14 |
| 1.3 Structure of BAFF and APRIL | 14 |
| 1.3.1 Structural Comparison to Other TNF Family Members | 14 |
| 1.3.2 BAFF Forms Virus-Like Particles | 15 |
| 1.3.3 APRIL Binds to Proteoglycans | 17 |
| 1.4 Receptor Binding | 18 |
| 1.4.1 Structure of BCMA, TACI, and BAFF-R | 18 |
| 1.4.2 Comparison of Ligand--Receptor Binding in the TNF Family | 19 |
| 1.4.3 Structural Determinants of Binding Specificity | 21 |
| 1.5 Receptor Signaling | 22 |
| 1.5.1 Signaling Overview | 22 |
| 1.5.2 TRAF Binding | 23 |
| 1.6 Oligomerization-Dependent Signaling | 24 |
| 1.7 Conclusions and Open Questions | 25 |
| References | 26 |
| 2 BAFF Receptor Regulation of Peripheral B-Lymphocyte Survival and Development | 30 |
|---|
| 2.1 Introduction | 30 |
| 2.2 Peripheral B-Cell Development | 31 |
| 2.3 BAFF/BR3 in B-Cell Survival and Development | 36 |
| 2.4 Mechanisms of BR3-Mediated B-Cell Survival | 37 |
| 2.5 Mechanisms of BAFF-Mediated Activation of Classical and Alternative NF-B Pathways | 39 |
| 2.6 A Unified View of How BCR and BR3 Regulate B-Cell Development and Activation: BCR-Positive Regulation of BR3-Induced NF-B Activation | 42 |
| References | 45 |
| 3 Regulation of B-Cell Self-Tolerance By BAFF and the Molecular Basis of Its Action | 53 |
|---|
| 3.1 Regulation of Self-Reactive B Cells by BAFF | 54 |
| 3.1.1 The Requirement for B-Cell Self-Tolerance | 54 |
| 3.1.2 Self-Tolerance Checkpoints During B-Cell Development | 54 |
| 3.1.2.1 Immature Bone Marrow B Cells | 54 |
| 3.1.2.2 Immature to Mature B-Cell Transition in the Periphery | 55 |
| 3.1.2.3 Marginal Zone B-Cell Development | 56 |
| 3.1.3 Points of Action of BAFF and BAFF-R During B-Cell Development | 57 |
| 3.1.4 BAFF and the Regulation of B-Cell Self-Tolerance Checkpoints | 58 |
| 3.1.4.1 Immature Bone Marrow B Cells | 58 |
| 3.1.4.2 Immature to Mature B-Cell Transition in the Periphery | 59 |
| 3.1.5 Marginal Zone B-Cell Development | 60 |
| 3.2 Signalling BAFF-Dependent B-Cell Survival | 61 |
| 3.2.1 The NF- B Signalling Pathways | 61 |
| 3.2.1.1 The Canonical NF-B Pathway | 62 |
| 3.2.1.2 The Alternative NF-B Pathway | 63 |
| 3.2.2 The Contribution of the Canonical NF- B Pathway to B-Cell Survival | 63 |
| 3.2.3 The Alternative NF- B Pathway Is the Major Contributor to B-Cell Survival Downstream of BAFF-R | 64 |
| 3.2.3.1 TRAF Proteins Are Fundamental Regulators of NF-B2 Signalling | 64 |
| 3.2.3.2 Unravelling the Proximal Signalling Events That Allow TRAFs to Suppress NF-B2 Signalling | 65 |
| 3.2.3.3 BAFF Is an Obligate Survival Factor for B Cells Because It Reverses the Suppression of NF-B2 | 67 |
| 3.2.4 Other Intracellular Mediators of B-Cell Survival Initiated by BAFF | 67 |
| 3.2.4.1 Increasing Glycolysis | 68 |
| 3.2.4.2 Modulation of Pro- and Anti-apoptotic Proteins | 68 |
| 3.3 Conclusions | 68 |
| References | 69 |
| 4 Role of BAFF and APRIL in Antibody Production and Diversification | 74 |
|---|
| 4.1 Introduction | 74 |
| 4.2 Role of BAFF and APRIL in B-Cell Survival and Activation | 75 |
| 4.2.1 Structure of BAFF and APRIL | 75 |
| 4.2.2 Expression of BAFF and APRIL | 75 |
| 4.2.3 BAFF and APRIL Receptors | 76 |
| 4.2.4 BAFF and APRIL Signaling | 76 |
| 4.2.5 Role of BAFF and APRIL in B-Cell Survival | 77 |
| 4.2.6 Role of BAFF and APRIL in B-Cell Activation and Differentiation | 78 |
| 4.3 Role of BAFF and APRIL in Antibody Production | 79 |
| 4.3.1 Regulation of Adaptive Immune Responses by DCs | 79 |
| 4.3.2 Role of Specific DC Subsets | 80 |
| 4.3.3 DC Regulation of TD Antibody Responses | 81 |
| 4.3.4 Function of BAFF and APRIL in TD Antibody Responses | 82 |
| 4.3.5 Role of TI Antibody Responses in Protective Immunity | 83 |
| 4.3.6 Dendritic Cell Regulation of TI Antibody Responses | 84 |
| 4.3.7 Function of BAFF and APRIL in TI Antibody Responses | 85 |
| 4.4 Role of BAFF and APRIL in Antibody Diversification | 87 |
| 4.4.1 Processes Mediating Antibody Diversification | 87 |
| 4.4.2 Mechanism and Requirements of Class Switching | 88 |
| 4.4.3 CD40L Signaling in TD Class Switching | 90 |
| 4.4.4 BAFF and APRIL Signaling in TI Class Switching | 91 |
| 4.5 Role of BAFF and APRIL in Antibody Disorders | 92 |
| 4.5.1 Autoimmune Disorders | 92 |
| 4.5.2 Immunodeficiencies | 93 |
| 4.6 Conclusions | 94 |
| References | 94 |
| 5 Signal Transduction by Receptors for BAFF and APRIL | 102 |
|---|
| 5.1 Proximal Signaling
|